These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31088701)

  • 1. Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia.
    Weickert CS; Lee CH; Lenroot RK; Bruggemann J; Galletly C; Liu D; Balzan R; Pillai A; Buckley P; Weickert TW
    Schizophr Res; 2019 Jul; 209():212-217. PubMed ID: 31088701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia.
    Skilleter AJ; Weickert CS; Vercammen A; Lenroot R; Weickert TW
    Psychol Med; 2015 Mar; 45(4):841-54. PubMed ID: 25162472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
    Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M
    Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia.
    Yang F; Wang K; Du X; Deng H; Wu HE; Yin G; Ning Y; Huang X; Teixeira AL; de Quevedo J; Soares JC; Li X; Lang X; Zhang XY
    Psychopharmacology (Berl); 2019 Feb; 236(2):753-762. PubMed ID: 30456540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.
    Miodownik C; Maayan R; Ratner Y; Lerner V; Pintov L; Mar M; Weizman A; Ritsner MS
    Clin Neuropharmacol; 2011; 34(4):155-60. PubMed ID: 21617527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.
    Primavera D; Manchia M; Deriu L; Tusconi M; Collu R; Scherma M; Fadda P; Fratta W; Carpiniello B
    BMJ Open; 2017 May; 7(5):e014938. PubMed ID: 28550022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.
    Zakharyan R; Boyajyan A
    Clin Biochem; 2014 Aug; 47(12):1052-5. PubMed ID: 24713399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
    Chiou YJ; Huang TL
    World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.
    Green MJ; Matheson SL; Shepherd A; Weickert CS; Carr VJ
    Mol Psychiatry; 2011 Sep; 16(9):960-72. PubMed ID: 20733577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
    World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.
    Jindal RD; Pillai AK; Mahadik SP; Eklund K; Montrose DM; Keshavan MS
    Schizophr Res; 2010 Jun; 119(1-3):47-51. PubMed ID: 20096541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study.
    Kudlek Mikulic S; Mihaljevic-Peles A; Sagud M; Bajs Janovic M; Ganoci L; Grubisin J; Kuzman Rojnic M; Vuksan Cusa B; Bradaš Z; Božina N
    Nord J Psychiatry; 2017 Oct; 71(7):513-520. PubMed ID: 28671000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients.
    Heitz U; Papmeyer M; Studerus E; Egloff L; Ittig S; Andreou C; Vogel T; Borgwardt S; Graf M; Eckert A; Riecher-Rössler A
    World J Biol Psychiatry; 2019 Sep; 20(7):545-554. PubMed ID: 29938562
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?
    Pillai A; Schooler NR; Peter D; Looney SW; Goff DC; Kopelowicz A; Lauriello J; Manschreck T; Mendelowitz A; Miller DD; Severe JB; Wilson DR; Ames D; Bustillo J; Kane JM; Buckley PF
    Schizophr Res; 2018 Mar; 193():263-268. PubMed ID: 28734907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls.
    Shimizu E; Hashimoto K; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Nakazato M; Kumakiri C; Okada S; Iyo M
    Neurosci Lett; 2003 Nov; 351(2):111-4. PubMed ID: 14583394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.
    Pillai A; Kale A; Joshi S; Naphade N; Raju MS; Nasrallah H; Mahadik SP
    Int J Neuropsychopharmacol; 2010 May; 13(4):535-9. PubMed ID: 19941699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics.
    González-Pinto A; Mosquera F; Palomino A; Alberich S; Gutiérrez A; Haidar K; Vega P; Barbeito S; Ortiz A; Matute C
    Int Clin Psychopharmacol; 2010 Jul; 25(4):241-5. PubMed ID: 20568658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.
    Pawełczyk T; Grancow-Grabka M; Trafalska E; Szemraj J; Żurner N; Pawełczyk A
    Psychopharmacology (Berl); 2019 Sep; 236(9):2811-2822. PubMed ID: 31098654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.